A carregar...
pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients.
Tamoxifen as sole initial therapy is gaining importance in the management of post-menopausal breast cancer patients. Age oestrogen (ER) and progesterone (PR) receptor status are accurately considered to select patients for hormonal treatment. However, additional markers are needed. By immunohistoche...
Na minha lista:
Main Authors: | , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Nature Publishing Group
1996
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2077113/ https://ncbi.nlm.nih.gov/pubmed/8855985 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|